MedMen and PharmaCann terminate $682 million cannabis merger; MedMen CFO ousted
MedMen, a Los Angeles-based multistate marijuana operator, announced that its blockbuster acquisition of PharmaCann has been scuttled and that the company will focus on beefing up its retail operations in California and other states.
Life has stabilized for California marijuana testing labs since 2018, but hurdles remain
California’s cannabis testing industry was stressed to the brink in 2018, with newly required testing thresholds going into effect first in July 2018 and then in January 2019.
The result at the time was long waits for test results, a temporary increase in product testing failures and various industry stakeholders arguing the state needed far more labs.
